Synthesis of aza-, oxa-, and thiabicyclo[3.1.0]hexane heterocycles from a common synthetic intermediate

Organic Letters

Volumn 7, Issue 13, 2005, Pages 2627-2630

  Renslo, Adam R ^a   Gao, Hongwu ^a   Jaishankar, Priyadarshini ^a   Venkatachalam, Revathy ^a   Gordeev, Mikhail F ^a  

^a Vicuron Pharmaceuticals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIINFECTIVE AGENT; CINNAMYL ALCOHOL; FUSED HETEROCYCLIC RINGS; HETEROCYCLIC COMPOUND; OXAZOLIDINONE DERIVATIVE; OXYGEN; PROPANOL; SULFUR DERIVATIVE;

ARTICLE; CATALYSIS; CHEMICAL STRUCTURE; CHEMISTRY; SYNTHESIS;

ANTI-BACTERIAL AGENTS; AZA COMPOUNDS; BICYCLO COMPOUNDS, HETEROCYCLIC; CATALYSIS; MOLECULAR STRUCTURE; OXAZOLIDINONES; OXYGEN; PROPANOLS; SULFUR COMPOUNDS;

EID: 29844437361     PISSN: 15237060     EISSN: None     Source Type: Journal    
DOI: 10.1021/ol050730h     Document Type: Article

References (31)

1. For recent examples, see: (a) Hanessian, S.; MacKay, D. B.; Moitessier J. Med. Chem. 2001, 44, 3074.
2. (b) Dutta, A. K.; Davis, M. C.; Reith, M. E. A. Bioorg. Med. Chem. Lett. 2001, 11, 2337.
3. (c) Ullrich, T.; Binder, D.; Pyerin, M. Tetrahedron Lett. 2002, 43, 177.
4. (d) Kolhatkar, R.; Cook, C. D.; Ghorai, S. K.; Deschamps, J.; Beardsley, P. M.; Reith, M. E. A.; Dutta, A. K. J. Med. Chem. 2004, 47, 5101.
5. Reviews: (a) Brickner, S. J. Curr. Pharm. Des. 1996, 2, 175.
6. (b) Hutchinson, D. K. Curr. Top. Med. Chem. 2003, 3, 1021-1042.
7. (c) Nilius, A. M. Curr. Opin. Invest. Drugs 2003, 4, 149.
8. Roulet, J.-M.; Deguin, B.; Vogel, P. J. Am. Chem. Soc. 1994, 116, 3639.
9. For a review, see: Krow, G. R.; Cannon, K. C. Org. Prep. Proced. Int. 2000, 32, 103.
10. (a) Brighty, K. E.; Castaldi, M. J. Synlett 1996, 1097.
11. (b) Braish, T. F.; Castaldi, M.; Chan, S.; Fox, D. E.; Keltonic, T.; McGarry, J.; Hawkins, J. M.; Norris, T.; Rose, P. R.; Sieser, J. E.; Sitter, B. J.; Watson, H., Jr. Synlett 1996, 1100.
12. (a) House, H. O.; Blankley, C. J. J. Org. Chem. 1968, 33, 53.
13. (b) Hudlicky, T.; Reddy, D. B.; Govindan, S. V.; Kulp, T.; Still, B.; Sheth, J. P. J. Org. Chem. 1983, 48, 3422.
14. (c) Doyle, M. P.; Austin, R. E.; Bailey, A. S.; Dwyer, M. P.; Dyatkin, A. B.; Kalinin, A. V.; Kwan, M. M. Y.; Liras, S.; Oalmann, C. J.; Pieters, R. J.; Protopopova, M. N.; Raab, C. E.; Roos, G. H. P.; Zhou, Q.-L.; Martin, S. F. J. Am. Chem. Soc. 1995, 117, 5763.
15. (a) Blankley, C. J.; Sauter, F. J.; House, H. O. Organic Syntheses; Wiley: New York, 1973; Collect. Vol. V, p 258;
16. (b) Corey, E. J.; Myers, A. G. Tetrahedron Lett. 1984, 3559.
17. Wolfe, J. P.; Wagaw, S.; Marcoux, J.-F.; Buchwald, S. L. Acc. Chem. Res. 1998, 31, 805.
18. (a) Devos, A.; Frisque-Hesbain, A.-M.; Colens, A.; Ghosez, L. J. Chem. Soc., Chem. Commun. 1979, 1180.
19. (b) Haveauz, B.; Dekoker, A.; Rens, M.; Sidani, A. R.; Toye, J.; Ghosez, L. Org. Synth. 1980, 59, 26.
20. (a) Charles, R. G. J. Org. Chem. 1957, 22, 677.
21. (b) Sacconi, L.; Ciampolini, M. J. Chem. Soc. 1964, 276.
22. 13C NMR spectra of 7 were compared to those reported for analogous phenyl-substituted bicyclic lactones (ref 6c and references cited therein) and were consistent with formation of the expected exo diastereomer.
23. This general cyclization approach has been described previously; see: Krow, G.; Hill, R. K. Chem. Commun. 1968, 430.
24. Reaction of the bis-mesylate with excess aqueous ammonium hydroxide in methanol-THF provided the desired amine along with multiple side products that were not characterized.
25. (a) Olofson, R. A.; Martz, J. T.; Senet, J.-P., Piteau, M.; Malfroot, T. J. Org. Chem. 1984, 49, 2081.
26. (b) Yang, B. V.; O'Rourke, D.; Li, J. Synlett 1993, 195.
27. An initial attempt to oxidatively cleave the PMB group in an advanced intermediate (4.0 equiv of CAN in acetonitrile-water) produced a complex reaction mixture. This approach was not investigated further.
28. Terunuma, D.; Kumano, K.; Motoyama, Y. Bull. Chem. Soc. Jpn. 1994, 67, 2763.
29. (a) Perrault, W. R.; Pearlman, B. A.; Godrej, D. B. Process to Prepare Oxazolidinones. U.S. Patent Application Publication U.S. 2002/0169312.
30. (b) Perrault, W. R.; Pearlman, B. A.; Godrej, D. B.; Jeganathan, A.; Yamagata, K.; Chen, J. J.; Lu, C. V.; Herrinton, P. M.; Gadwood, R. C.; Chan, L.; Lyster, M. A.; Maloney, M. T.; Moeslein, J. A.; Greene, M. L.; Barbachyn, M. R. Org. Process Res. Dev. 2003, 7, 533-546.
31. MICs for compound 21 were ≤ 4 mg/L against a panel of Staphylococcus. aureus, Streptococcus pneumoniae, and Haemophilus influenzae strains.